Atlas Trials

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Clinical trial NCT00567346 · COMPLETED

Trial details

NCT number
NCT00567346
Sponsor
Artu Biologicals
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Allergic Rhinoconjunctivitis
Start date
2006-12-01
Primary completion
2007-10-01
Enrollment
605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.